InChI=1S/C35H49N11O9S2/c36- 30(51) 25- 18- 57- 56- 13- 10- 27(47) 42- 22(8- 3- 4- 11- 39- 35(37) 38) 31(52) 41- 17- 28(48) 43- 23(15- 29(49) 50) 32(53) 44- 24(14- 19- 16- 40- 21- 7- 2- 1- 6- 20(19) 21) 34(55) 46- 12- 5- 9- 26(46) 33(54) 45- 25/h1- 2,6- 7,16,22- 26,40H,3- 5,8- 15,17- 18H2,(H2,36,51) (H,41,52) (H,42,47) (H,43,48) (H,44,53) (H,45,54) (H,49,50) (H4,37,38,39) /t22- ,23- ,24- ,25- ,26- /m0/s1 |
CZKPOZZJODAYPZ-LROMGURASA-N |
[H] [C@@] 1(Cc2c[nH] c3ccccc23) NC(=O) [C@H] (CC(O) =O) NC(=O) CNC(=O) [C@H] (CCCCNC(N) =N) NC(=O) CCSSC[C@H] (NC(=O) [C@@H] 2CCCN2C1=O) C(N) =O |
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
platelet aggregation inhibitor
A drug or agent which antagonizes or impairs any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
anticoagulant
An agent that prevents blood clotting.
|
|
View more via ChEBI Ontology
[(3R,11S,17S,20S,25aS)- 11- (4- carbamimidamidobutyl)- 3- carbamoyl- 20- (1H- indol- 3- ylmethyl)- 1,9,12,15,18,21- hexaoxodocosahydro- 7H- pyrrolo[2,1- g][1,2,5,8,11,14,17,20]dithiahexaazacyclotricosin- 17- yl]acetic acid
|
EPTIFIBATIDE
|
ChEMBL
|
N6- amidino- N2- (3- mercaptopropionyl)- L- lysylglycyl- L- α- aspartyl- L- tryptophyl- L- prolyl- L- cysteinamide, cyclic(1- 6)- disulfide
|
ChemIDplus
|
S1,S6- cyclo[N6- carbamimidoyl- N2- (3- sulfanylpropanoyl)- L- lysylglycyl- L- α- aspartyl- L- tryptophyl- L- prolyl- L- cysteinamide]
|
ChEBI
|
188627-80-7
|
CAS Registry Number
|
ChemIDplus
|
9608167
|
Beilstein Registry Number
|
Beilstein
|
|